Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...
Brain oedema after major ischaemic infarction is a life-threatening complication for which no preventive therapy exists. Decompressive hemicraniectomy can be lifesaving and improve functional outcomes ...
Data from recent trials suggest that colchicine reduces ... stroke, or unplanned ischemia-driven coronary revascularization, evaluated in a time-to-event analysis. C-reactive protein was measured ...
In an ischemic stroke, a blood vessel becomes blocked ... Broderick said due to the time limitations, the trial will also ...
In addition to numerous published non-clinical studies of ischemia/hypoxia and anemia, over 300 individuals in 12 clinical trials have received single or multiple dose treatments with PP-007 ...
Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...
It was safe to start direct oral anticoagulant (DOAC) therapy without delay after acute ischemic stroke in people with atrial ...
The CardiAMP HF Trial is assessing the safety and effectiveness of the CardiAMP ® Cell Therapy ... CardiAMP HF also includes an open label roll-in cohort of ten patients, for a total of 125 patients.